A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME.
Transforming Growth Factor Beta1 has been studied across 20 research domains including 🔬 Oncology, ✨ Skin & Hair, 🦴 Bone & Joint, 🔬 Inflammation, 🛡️ Immunity. The primary research focus is 🔬 Oncology with 17% of studies addressing this area.
This evidence profile for Transforming Growth Factor Beta1 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.